Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4

• Main Authors: Christian R.H. Raetz, Teresa A. Garrett, C. Michael Reynolds, Walter A. Shaw, Jeff D. Moore, Dale C. Smith, Jr., Anthony A. Ribeiro, Robert C. Murphy, Richard J. Ulevitch, Colleen Fearns, Donna Reichart, Christopher K. Glass, Chris Benner, Shankar Subramaniam, Richard Harkewicz, Rebecca C. Bowers-Gentry, Matthew W. Buczynski, Jennifer A. Cooper, Raymond A. Deems, Edward A. Dennis
• Format: Article
• Language: English
• Published: Elsevier 2006-05-01
• Series: Journal of Lipid Research
• Subjects: 3-deoxy-d-manno-octulosonic acid-Lipid A; Escherichia coli; Re; endotoxin; macrophage; mass spectrometry
• Online Access: http://www.sciencedirect.com/science/article/pii/S0022227520332594

The LIPID MAPS Consortium (www.lipidmaps.org) is developing comprehensive procedures for identifying all lipids of the macrophage, following activation by endotoxin. The goal is to quantify temporal and spatial changes in lipids that occur with cellular metabolism and to develop bioinformatic approaches that establish dynamic lipid networks. To achieve these aims, an endotoxin of the highest possible analytical specification is crucial. We now report a large-scale preparation of 3-deoxy-d-manno-octulosonic acid (Kdo)2-Lipid A, a nearly homogeneous Re lipopolysaccharide (LPS) sub-structure with endotoxin activity equal to LPS. Kdo2-Lipid A was extracted from 2 kg cell paste of a heptose-deficient Escherichia coli mutant. It was purified by chromatography on silica, DEAE-cellulose, and C18 reverse-phase resin. Structure and purity were evaluated by electrospray ionization/mass spectrometry, liquid chromatography/mass spectrometry and 1H-NMR. Its bioactivity was compared with LPS in RAW 264.7 cells and bone marrow macrophages from wild-type and toll-like receptor 4 (TLR-4)-deficient mice. Cytokine and eicosanoid production, in conjunction with gene expression profiling, were employed as readouts. Kdo2-Lipid A is comparable to LPS by these criteria. Its activity is reduced by >103 in cells from TLR-4-deficient mice. The purity of Kdo2-Lipid A should facilitate structural analysis of complexes with receptors like TLR-4/MD2.